Organogenesis
Price & Volume
Stats
See more52W Range | $2.21-$7.07 |
Market Cap | $322.8M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $564.1M |
Revenue Growth (YoY) | 78.1% |
Gross Profit (12 Mos) | $426.6M |
Diluted EPS | $0.15 |
News
See moreYahoo Finance • 10 days ago
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
Yahoo Finance • 10 days ago
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Yahoo Finance • 2 months ago
Organogenesis projects 25%-38% revenue decline in 2026 amid CMS-driven market disruption
Yahoo Finance • 4 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
About
CEO | Mr. Gary S. Gillheeney Sr. |
Address | 85 Dan Road, Canton, MA, United States, 02021 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 854 |
